Home › Pagkabigo ng Puso › Florida › Orlando
Pag-aaral pangklinika para sa Pagkabigo ng Puso sa Orlando, FL
16 pag-aaral para sa Pagkabigo ng Puso ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Orlando (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction
Nagre-recruitPhase 1
- Flourish Research, Winter Park · 5 mi ang layo
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
Nagre-recruitPhase 3
- Flourish Research, Winter Park · 5 mi ang layo
A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart
Nagre-recruitPhase 3
- Flourish Research, Winter Park · 5 mi ang layo
Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure
Nagre-recruit
- AdventHealth Orlando, Orlando
Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction
Nagre-recruitPhase 3
- AdventHealth, Orlando
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Nagre-recruitPhase 3
- AdventHealth Orlando, Orlando
- Orlando Health Heart Institute, Orlando
- Guardian Research Organization LLC, Winter Park · 5 mi ang layo
- at 1 pa
CCM OPEN HF Registry
Nagre-recruitObservasyonal na pag-aaral
- AdventHealth Orlando, Orlando
A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)
Nagre-recruitPhase 2
- Clinical Site Partners, LLC dba Flourish Research, Winter Park · 5 mi ang layo
Assessment of CCM in HF With Higher Ejection Fraction
Nagre-recruit
- AdventHealth Orlando, Orlando
- Clinical One Research, Orlando
Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin
Nagre-recruitPhase 3
- Research Site, Orlando
A Research Study Comparing Different Doses of CDR132L With Placebo on the Structure and Function of the Heart in People With Heart Failure With Preserved Ejection Fraction and Left Ventricular Hypertrophy
Nagre-recruitPhase 2
- AdventHealth Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi ang layo
Feasibility and Efficacy Study of the CardioPulmonary Management (CPM) System in Patients With Chronic Heart Failure
Nagre-recruit
- Orlando Health, Orlando
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Nagre-recruitPhase 3
- Cardiovascular Institute of Orlando, Orlando
- Guardian Research Org LLC, Winter Park · 5 mi ang layo
- K2 Medical Research, Maitland · 6 mi ang layo
Alleviant ALLAY-HF Study
Nagre-recruit
- Advent Health Orlando, Orlando
The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With FMR
Nagre-recruit
- Advent Health Hospital, Orlando
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease
Nagre-recruitPhase 3
- AdventHealth, Orlando
Pag-aaral para sa Pagkabigo ng Puso sa ibang lungsod
- New York City, NY51 pag-aaral
- Boston, MA46 pag-aaral
- Dallas, TX42 pag-aaral
- Houston, TX35 pag-aaral
- Cleveland, OH31 pag-aaral
- Philadelphia, PA31 pag-aaral
- San Francisco, CA29 pag-aaral
- Chicago, IL28 pag-aaral
- Durham, NC25 pag-aaral
- Kansas City, MO25 pag-aaral
- St. Louis, MO24 pag-aaral
- Indianapolis, IN24 pag-aaral
Iba pang pag-aaral sa Orlando
- Non-Small Cell Lung Cancer47 pag-aaral
- Obesity33 pag-aaral
- Sakit ni Alzheimer29 pag-aaral
- Metastatic Cancer28 pag-aaral
- Overweight27 pag-aaral
- Type 2 Diabetes25 pag-aaral
- Kanser sa Ovary24 pag-aaral
- Kanser (lahat ng uri)24 pag-aaral
- Kanser sa Suso23 pag-aaral
- Kanser sa Baga23 pag-aaral
- Ulcerative Colitis21 pag-aaral
- Colorectal Cancer21 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.